Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.
Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease.
Anyone at risk of hepatitis B exposure or needing routine screening should undergo this test. This includes individuals with potential exposure through sexual contact, blood transfusions, or needle-sharing.
Yes, the HBSAg Spot Test is highly accurate in detecting hepatitis B surface antigen. However, a positive result requires confirmation through additional tests.
No, additional tests are needed to differentiate between acute and chronic hepatitis B infection.
A positive result indicates possible hepatitis B infection. Further confirmatory tests and counseling will be provided to determine the next steps for treatment and care.
The Anti-dsDNA Antibody Test detects antibodies against double-stranded DNA, which are commonly associated with autoimmune diseases like Systemic Lupus Erythematosus (SLE).
This test is used to diagnose SLE, monitor disease activity, assess treatment response, and differentiate between autoimmune diseases.
No special preparation is needed. You can eat and drink normally. Inform your healthcare provider about any medications or health conditions.
Results are typically available within 1 to 2 days after the test.
A positive result suggests the presence of antibodies associated with autoimmune activity, particularly in Systemic Lupus Erythematosus (SLE). Further evaluation is often required to confirm the diagnosis and assess disease activity.
Risks may include bleeding, infection, blood clots, or damage to blood vessels. However, the minimally invasive nature of the procedure reduces these risks.